0001363585-12-000006.txt : 20120621
0001363585-12-000006.hdr.sgml : 20120621
20120621185726
ACCESSION NUMBER: 0001363585-12-000006
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120620
FILED AS OF DATE: 20120621
DATE AS OF CHANGE: 20120621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brusegard David
CENTRAL INDEX KEY: 0001516920
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-25169
FILM NUMBER: 12920679
MAIL ADDRESS:
STREET 1: 33 HARBOUR SQUARE
CITY: TORONTO
STATE: A6
ZIP: M5J 2G2
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP
CENTRAL INDEX KEY: 0001059784
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 820490211
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0731
BUSINESS ADDRESS:
STREET 1: 33 HARBOUR SQ
STREET 2: STE 202
CITY: TORONTO ONTARIO CANADA
STATE: A1
ZIP: M5J 2G2
BUSINESS PHONE: 4163642551
MAIL ADDRESS:
STREET 1: 33 HARBOUR SQ
STREET 2: STE 202
CITY: TORONTO ONTARIO CA
STATE: A1
ZIP: M5J 2G2
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0305
4
2012-06-20
0
0001059784
GENEREX BIOTECHNOLOGY CORP
GNBT
0001516920
Brusegard David
33 HARBOUR SQUARE
TORONTO
A6
M5J 2G2
ONTARIO, CANADA
0
1
0
0
Chief Operating Officer
Common Stock Purchase Option (right to buy)
0.001
2012-06-20
4
A
0
546448
0
A
2012-06-20
2017-06-20
Common Stock
546448
546448
D
On June 6, 2012, the Board of Directors of the issuer granted the reporting person options to purchase 546,448 shares of the issuer's common stock in lieu of cash payment of deferred compensation, which grant was effective upon the reporting person's execution of a Settlement and Release Agreement with the issuer on June 20, 2012. The grant was made pursuant to the terms of the issuer's 2006 stock plan.
David Brusegard
2012-06-21